Copyright Reports & Markets. All rights reserved.

Global Vial and Prefilled Syringe Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Vial and Prefilled Syringe Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Vial and Prefilled Syringe Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Vial and Prefilled Syringe Market Size Growth Rate by Type
    • 1.4.2 Glass Vial and Prefilled Syringe
    • 1.4.3 Polymer Vial and Prefilled Syringe
  • 1.5 Market by Application
    • 1.5.1 Global Vial and Prefilled Syringe Market Size Growth Rate by Application
    • 1.5.2 Antithrombotics
    • 1.5.3 Vaccines
    • 1.5.4 Autoimmune Diseases
    • 1.5.5 Anti-inflammatory Drugs
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Vial and Prefilled Syringe Market Size, Estimates and Forecasts
    • 2.1.1 Global Vial and Prefilled Syringe Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Vial and Prefilled Syringe Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Vial and Prefilled Syringe Production Estimates and Forecasts 2015-2026
  • 2.2 Global Vial and Prefilled Syringe, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Vial and Prefilled Syringe Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Vial and Prefilled Syringe Manufacturers Geographical Distribution
  • 2.4 Key Trends for Vial and Prefilled Syringe Markets & Products
  • 2.5 Primary Interviews with Key Vial and Prefilled Syringe Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Vial and Prefilled Syringe Manufacturers by Production Capacity
    • 3.1.1 Global Top Vial and Prefilled Syringe Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Vial and Prefilled Syringe Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Vial and Prefilled Syringe Manufacturers Market Share by Production
  • 3.2 Global Top Vial and Prefilled Syringe Manufacturers by Revenue
    • 3.2.1 Global Top Vial and Prefilled Syringe Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Vial and Prefilled Syringe Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Vial and Prefilled Syringe Revenue in 2019
  • 3.3 Global Vial and Prefilled Syringe Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Vial and Prefilled Syringe Production by Regions

  • 4.1 Global Vial and Prefilled Syringe Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Vial and Prefilled Syringe Regions by Production (2015-2020)
    • 4.1.2 Global Top Vial and Prefilled Syringe Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Vial and Prefilled Syringe Production (2015-2020)
    • 4.2.2 North America Vial and Prefilled Syringe Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Vial and Prefilled Syringe Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Vial and Prefilled Syringe Production (2015-2020)
    • 4.3.2 Europe Vial and Prefilled Syringe Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Vial and Prefilled Syringe Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Vial and Prefilled Syringe Production (2015-2020)
    • 4.4.2 China Vial and Prefilled Syringe Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Vial and Prefilled Syringe Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Vial and Prefilled Syringe Production (2015-2020)
    • 4.5.2 Japan Vial and Prefilled Syringe Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Vial and Prefilled Syringe Import & Export (2015-2020)

5 Vial and Prefilled Syringe Consumption by Region

  • 5.1 Global Top Vial and Prefilled Syringe Regions by Consumption
    • 5.1.1 Global Top Vial and Prefilled Syringe Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Vial and Prefilled Syringe Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Vial and Prefilled Syringe Consumption by Application
    • 5.2.2 North America Vial and Prefilled Syringe Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Vial and Prefilled Syringe Consumption by Application
    • 5.3.2 Europe Vial and Prefilled Syringe Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Vial and Prefilled Syringe Consumption by Application
    • 5.4.2 Asia Pacific Vial and Prefilled Syringe Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Vial and Prefilled Syringe Consumption by Application
    • 5.5.2 Central & South America Vial and Prefilled Syringe Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Vial and Prefilled Syringe Consumption by Application
    • 5.6.2 Middle East and Africa Vial and Prefilled Syringe Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Vial and Prefilled Syringe Market Size by Type (2015-2020)
    • 6.1.1 Global Vial and Prefilled Syringe Production by Type (2015-2020)
    • 6.1.2 Global Vial and Prefilled Syringe Revenue by Type (2015-2020)
    • 6.1.3 Vial and Prefilled Syringe Price by Type (2015-2020)
  • 6.2 Global Vial and Prefilled Syringe Market Forecast by Type (2021-2026)
    • 6.2.1 Global Vial and Prefilled Syringe Production Forecast by Type (2021-2026)
    • 6.2.2 Global Vial and Prefilled Syringe Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Vial and Prefilled Syringe Price Forecast by Type (2021-2026)
  • 6.3 Global Vial and Prefilled Syringe Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Vial and Prefilled Syringe Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Vial and Prefilled Syringe Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 BD (US)
    • 8.1.1 BD (US) Corporation Information
    • 8.1.2 BD (US) Overview
    • 8.1.3 BD (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 BD (US) Product Description
    • 8.1.5 BD (US) Related Developments
  • 8.2 Gerresheimer (DE)
    • 8.2.1 Gerresheimer (DE) Corporation Information
    • 8.2.2 Gerresheimer (DE) Overview
    • 8.2.3 Gerresheimer (DE) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Gerresheimer (DE) Product Description
    • 8.2.5 Gerresheimer (DE) Related Developments
  • 8.3 Nipro Corporation (JP)
    • 8.3.1 Nipro Corporation (JP) Corporation Information
    • 8.3.2 Nipro Corporation (JP) Overview
    • 8.3.3 Nipro Corporation (JP) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Nipro Corporation (JP) Product Description
    • 8.3.5 Nipro Corporation (JP) Related Developments
  • 8.4 Schott forma vitrum (DE)
    • 8.4.1 Schott forma vitrum (DE) Corporation Information
    • 8.4.2 Schott forma vitrum (DE) Overview
    • 8.4.3 Schott forma vitrum (DE) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Schott forma vitrum (DE) Product Description
    • 8.4.5 Schott forma vitrum (DE) Related Developments
  • 8.5 Ompi (IT)
    • 8.5.1 Ompi (IT) Corporation Information
    • 8.5.2 Ompi (IT) Overview
    • 8.5.3 Ompi (IT) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Ompi (IT) Product Description
    • 8.5.5 Ompi (IT) Related Developments
  • 8.6 Baxter BioPharma Solution (US)
    • 8.6.1 Baxter BioPharma Solution (US) Corporation Information
    • 8.6.2 Baxter BioPharma Solution (US) Overview
    • 8.6.3 Baxter BioPharma Solution (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Baxter BioPharma Solution (US) Product Description
    • 8.6.5 Baxter BioPharma Solution (US) Related Developments
  • 8.7 ROVI CM (ES)
    • 8.7.1 ROVI CM (ES) Corporation Information
    • 8.7.2 ROVI CM (ES) Overview
    • 8.7.3 ROVI CM (ES) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 ROVI CM (ES) Product Description
    • 8.7.5 ROVI CM (ES) Related Developments
  • 8.8 Terumo (JP)
    • 8.8.1 Terumo (JP) Corporation Information
    • 8.8.2 Terumo (JP) Overview
    • 8.8.3 Terumo (JP) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Terumo (JP) Product Description
    • 8.8.5 Terumo (JP) Related Developments
  • 8.9 Vetter (DE)
    • 8.9.1 Vetter (DE) Corporation Information
    • 8.9.2 Vetter (DE) Overview
    • 8.9.3 Vetter (DE) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Vetter (DE) Product Description
    • 8.9.5 Vetter (DE) Related Developments
  • 8.10 Unilife Corporation (US)
    • 8.10.1 Unilife Corporation (US) Corporation Information
    • 8.10.2 Unilife Corporation (US) Overview
    • 8.10.3 Unilife Corporation (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Unilife Corporation (US) Product Description
    • 8.10.5 Unilife Corporation (US) Related Developments
  • 8.11 Taisei Kako (JP)
    • 8.11.1 Taisei Kako (JP) Corporation Information
    • 8.11.2 Taisei Kako (JP) Overview
    • 8.11.3 Taisei Kako (JP) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Taisei Kako (JP) Product Description
    • 8.11.5 Taisei Kako (JP) Related Developments
  • 8.12 Roselabs Group (IN)
    • 8.12.1 Roselabs Group (IN) Corporation Information
    • 8.12.2 Roselabs Group (IN) Overview
    • 8.12.3 Roselabs Group (IN) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Roselabs Group (IN) Product Description
    • 8.12.5 Roselabs Group (IN) Related Developments
  • 8.13 ARTE CORPORATION (JP)
    • 8.13.1 ARTE CORPORATION (JP) Corporation Information
    • 8.13.2 ARTE CORPORATION (JP) Overview
    • 8.13.3 ARTE CORPORATION (JP) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 ARTE CORPORATION (JP) Product Description
    • 8.13.5 ARTE CORPORATION (JP) Related Developments
  • 8.14 Weigao Group Medical Polymer (CN)
    • 8.14.1 Weigao Group Medical Polymer (CN) Corporation Information
    • 8.14.2 Weigao Group Medical Polymer (CN) Overview
    • 8.14.3 Weigao Group Medical Polymer (CN) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Weigao Group Medical Polymer (CN) Product Description
    • 8.14.5 Weigao Group Medical Polymer (CN) Related Developments
  • 8.15 Zibo Minkang Pharmaceutical (CN)
    • 8.15.1 Zibo Minkang Pharmaceutical (CN) Corporation Information
    • 8.15.2 Zibo Minkang Pharmaceutical (CN) Overview
    • 8.15.3 Zibo Minkang Pharmaceutical (CN) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.15.4 Zibo Minkang Pharmaceutical (CN) Product Description
    • 8.15.5 Zibo Minkang Pharmaceutical (CN) Related Developments
  • 8.16 Shandong Pharmaceutical Glass (CN)
    • 8.16.1 Shandong Pharmaceutical Glass (CN) Corporation Information
    • 8.16.2 Shandong Pharmaceutical Glass (CN) Overview
    • 8.16.3 Shandong Pharmaceutical Glass (CN) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.16.4 Shandong Pharmaceutical Glass (CN) Product Description
    • 8.16.5 Shandong Pharmaceutical Glass (CN) Related Developments

9 Vial and Prefilled Syringe Production Forecast by Regions

  • 9.1 Global Top Vial and Prefilled Syringe Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Vial and Prefilled Syringe Regions Forecast by Production (2021-2026)
  • 9.3 Key Vial and Prefilled Syringe Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Vial and Prefilled Syringe Consumption Forecast by Region

  • 10.1 Global Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)
  • 10.2 North America Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Vial and Prefilled Syringe Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Vial and Prefilled Syringe Sales Channels
    • 11.2.2 Vial and Prefilled Syringe Distributors
  • 11.3 Vial and Prefilled Syringe Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Vial and Prefilled Syringe Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Vial and Prefilled Syringe Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Vial and Prefilled Syringe Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Vial and Prefilled Syringe market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vial and Prefilled Syringe market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Vial and Prefilled Syringe market is segmented into
    Glass Vial and Prefilled Syringe
    Polymer Vial and Prefilled Syringe

    Segment by Application, the Vial and Prefilled Syringe market is segmented into
    Antithrombotics
    Vaccines
    Autoimmune Diseases
    Anti-inflammatory Drugs
    Other

    Regional and Country-level Analysis
    The Vial and Prefilled Syringe market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Vial and Prefilled Syringe market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Vial and Prefilled Syringe Market Share Analysis

    Vial and Prefilled Syringe market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Vial and Prefilled Syringe by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Vial and Prefilled Syringe business, the date to enter into the Vial and Prefilled Syringe market, Vial and Prefilled Syringe product introduction, recent developments, etc.
    The major vendors covered:
    BD (US)
    Gerresheimer (DE)
    Nipro Corporation (JP)
    Schott forma vitrum (DE)
    Ompi (IT)
    Baxter BioPharma Solution (US)
    ROVI CM (ES)
    Terumo (JP)
    Vetter (DE)
    Unilife Corporation (US)
    Taisei Kako (JP)
    Roselabs Group (IN)
    ARTE CORPORATION (JP)
    Weigao Group Medical Polymer (CN)
    Zibo Minkang Pharmaceutical (CN)
    Shandong Pharmaceutical Glass (CN)

    Buy now